As the global economy mends, the 2021 growth of Constipation Treatment Drug will have significant change from previous year. According to our (LP Information) latest study, the global Constipation Treatment Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Constipation Treatment Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Constipation Treatment Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Constipation Treatment Drug market, reaching US$ million by the year 2028. As for the Europe Constipation Treatment Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Constipation Treatment Drug players cover AstraZeneca, Bayer AG, Sanofi, and Sucampo Pharmaceuticals, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Constipation Treatment Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Laxatives
Chloride Channel Activators
5-HT4 Receptor Agonists
GC-C Agonists
Peripherally Acting Mu-Opioid Receptor Antagonists
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
Bayer AG
Sanofi
Sucampo Pharmaceuticals, Inc.
Takeda Pharmaceuticals Company Limited
Ironwood Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc.
Abbott Laboratories
Cosmo Pharmaceuticals NV
Synergy Pharmaceuticals, Inc.
Prestige Brands Holdings, Inc.
Janssen Pharmaceutical Company
Shionogi & Co., Ltd.
Renexxion, LLC
Daewoong Pharmaceuticals Co. Ltd.
Albireo Pharma, Inc.